HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Consumer Reports Has 'Concerns' About Echinacea, Turmeric Supplements

Executive Summary

Nonprofit advocacy group says one third of echinacea and turmeric supplements it tested contained ingredients in amounts lower than labeled or elevated levels of lead or bacteria. Industry groups say CR used "arbitrary" standards based on preconceived, critical view of US supplement regulation.

You may also be interested in...



Labs' High-Performance Chromatography Results Don't Help Dakota Nutrition's Elderberry Claims

NAD’s review was shorter than it might have been because Dakota Nutrition stopped using around 30 challenged disease claims, leaving a total of eight claims made on labels, its website and online retailers’ platforms about the amount of elderberry in its products.

US FDA-Funded Study Spurs Consumer Reports’ Latest Lament On VMS Market Oversight

Abstract of study notes methylsynephrine and isopropyloctopamine found in bitter orange supplements aren’t permitted by FDA as dietary ingredients. CR says despite the findings, FDA hasn't enforced against manufacturers or warned consumers.

FDA Suggests Legislation To Streamline Enforcement In Supplement Market

Congress should consider legislation authorizing agency to conduct enforcement more directly, says Associate Commissioner Schiller. In FDLI conference keynote, he discussed compliance with FDA regulations across markets it regulates, but made specific example of saying FDA is comparatively hamstrung in regulating businesses marketing products labeled as supplements.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149390

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel